| Derivation cohort (n = 1008) | Validation cohort (n = 1031) |
---|---|---|
Age, years | 55 (44–65) | 63 (52–70) |
Sex, female | 439 (43.6%) | 493 (47.8%) |
Current smoke status* | 57 (10.5%) | – |
Neutrophil count, × 109/L | 4.40 (2.79–6.96) | 3.90 (2.78–5.68) |
Lymphocyte count*, × 109/L | 0.95 (0.61–1.34) | 1.07 (0.70–1.49) |
Platelet count*, × 109/L | 194 (145–256) | 219 (164–288) |
Haemoglobin*, g/L | 126 (115–138) | – |
Chronic pulmonary disease | 40 (4.0%) | – |
Hypertension | 232 (23.0%) | 383 (37.1%) |
Coronary heart disease | 32 (3.2%) | 83 (8.1%) |
Diabetes | 110 (10.9%) | 189 (18.3%) |
Thyroid disease | 31 (3.1%) | – |
Chronic digestive disease | 78 (7.7%) | – |
Cerebrovascular disease | 22 (2.2%) | – |
Chronic kidney disease | 25 (2.5%) | – |
Malignancy | 31 (3.1%) | – |